Announcement on Convening the Q3 2026 Performance Briefing
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(688656)"HOB BIOTECH GROUP CORP., LTD."Announcement on Convening the Q3 2026 Performance Briefing
Filed with SSE · Stock code 688656 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)HOB Biotech Group Corp., Ltd. on 6ix
Story so far
- (688656)"HOB BIOTECH GROUP CORP., LTD."Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate by Wholly-owned Subsidiary
- Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate by Wholly-owned Subsidiary
- Notice on Convening the 3rd Extraordinary General Meeting in 2026
Earlier from HOB Biotech
- (688656)"HOB BIOTECH GROUP CORP., LTD."Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate by Wholly-owned Subsidiary
- Self-inspection Report on Trading in the Company's Shares by Insiders in Relation to the 2026 Restricted Share Incentive Plan
- Statement and Review Opinion on the Public Disclosure of the List of Participants for the Initial Grant under the Company's 2026 Restricted Share Incentive Plan Issued by the Remuneration and Appraisal Committee of the Board of Directors
- Notice on Convening the 3rd Extraordinary General Meeting in 2026
- Semi-annual Report for 2026
Follow HOB Biotech into a list and get an email when it puts out news.
Follow HOB Biotech